Shock or feedback? new study tests best way to fix stroke shoulder pain

NCT ID NCT07423455

Not yet recruiting Symptom relief Sponsor: Şahide Eda ARTUÇ Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two therapies—neuromuscular electrical stimulation (NMES) and EMG biofeedback—for treating shoulder subluxation in stroke survivors. Thirty-six participants will receive one of the therapies plus standard physiotherapy for three weeks. The goal is to see which approach better improves shoulder stability, reduces pain, and enhances quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Neuromuscular electrical stimulation (NMES) and electromyographic (EMG) biofeedback
What this could lead to: If successful, this study could show which therapy is more effective for improving shoulder stability and reducing pain in stroke survivors with shoulder subluxation.
What could go wrong: This is a small, early-stage trial with only 36 participants, so results may not apply to all stroke patients. The therapies may show no significant difference or benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLENOHUMERAL SUBLUXATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Shoulder Dislocation stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLENOHUMERAL SUBLUXATION STROKE

Contacts and locations

Locations

Gaziler Physical Therapy and Rehabilitation Training and Research Hospital

Ankara, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.